{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T04:00:51Z","timestamp":1790740851474,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T00:00:00Z","timestamp":1787097600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82272276"],"award-info":[{"award-number":["82272276"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020084","name":"Guangzhou Municipal Science and Technology Bureau","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020084","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012576","name":"Guangdong Basic and Applied Basic Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012576","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024A1515010477"],"award-info":[{"award-number":["2024A1515010477"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Oncology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.tranon.2026.102986","type":"journal-article","created":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:55:48Z","timestamp":1788332148000},"page":"102986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player"],"prefix":"10.1016","volume":"72","author":[{"given":"Shu","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanfan","family":"Zhong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yixun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Le","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9685-7003","authenticated-orcid":false,"given":"Ronghua","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.tranon.2026.102986_bib0001","first-page":"485","article-title":"Prostate cancer statistics, 2025","volume":"75","author":"Kratzer","year":"2025","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.tranon.2026.102986_bib0002","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.216739","article-title":"Identification of a 9-gene signature to enhance biochemical recurrence prediction in primary prostate cancer: a benchmarking study using ten machine learning methods and twelve patient cohorts","volume":"588","author":"Yin","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.102986_bib0003","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajur.2025.06.003","article-title":"Decision regret after robot-assisted radical prostatectomy: a systematic review and meta-analysis","volume":"13","author":"Longoni","year":"2026","journal-title":"Asian J. Urol."},{"key":"10.1016\/j.tranon.2026.102986_bib0004","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2024.217155","article-title":"Advances in and prospects of immunotherapy for prostate cancer","volume":"601","author":"Liu","year":"2024","journal-title":"Cancer Lett."},{"key":"10.1016\/j.tranon.2026.102986_bib0005","doi-asserted-by":"crossref","DOI":"10.1038\/s41391-025-01067-3","article-title":"Enzalutamide in metastatic hormone-sensitive prostate cancer: results from the international, multicentre, real-world ARON-3 study","author":"B\u00fcttner","year":"2026","journal-title":"Prostate Cancer Prostatic. Dis."},{"key":"10.1016\/j.tranon.2026.102986_bib0006","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.euo.2024.11.005","article-title":"Apalutamide in metastatic castration-sensitive prostate cancer: results from the Multicenter real-world ARON-3 study","volume":"8","author":"Santoni","year":"2025","journal-title":"Eur. Urol. Oncol."},{"key":"10.1016\/j.tranon.2026.102986_bib0007","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1002\/mc.23201","article-title":"ARNT-dependent CCR8 reprogrammed LDH isoform expression correlates with poor clinical outcomes of prostate cancer","volume":"59","author":"Chen","year":"2020","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.tranon.2026.102986_bib0008","doi-asserted-by":"crossref","DOI":"10.3390\/ijms222413519","article-title":"An insight on novel molecular pathways in metastatic prostate cancer: a focus on DDR, MSI and AKT","volume":"22","author":"Mollica","year":"2021","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.tranon.2026.102986_bib0009","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14040907","article-title":"PARP inhibitors and radiometabolic approaches in metastatic castration-resistant prostate cancer: what's now, what's new, and what's coming?","volume":"14","author":"Marchetti","year":"2022","journal-title":"Cancers"},{"key":"10.1016\/j.tranon.2026.102986_bib0010","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/s41573-025-01280-8","article-title":"RNA modification systems as therapeutic targets","volume":"25","author":"Zhang","year":"2026","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.tranon.2026.102986_bib0011","first-page":"53","article-title":"Beyond RNA modification: a novel role for tRNA modifying enzyme in oxidative stress response and metabolism","author":"Fruchard","year":"2025","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0012","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.ccell.2025.12.001","article-title":"Epitranscriptomic control of cancer hallmarks: functions, mechanisms, and therapeutics of RNA modifications","volume":"44","author":"Deng","year":"2026","journal-title":"Cancer Cell"},{"key":"10.1016\/j.tranon.2026.102986_bib0013","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.70190","article-title":"Deciphering the pseudouridine nucleobase modification in human diseases: from molecular mechanisms to clinical perspectives","volume":"15","author":"Jia","year":"2025","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102986_bib0014","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2478\/jtim-2022-0025","article-title":"Research progress on N(6)-adenosylate methylation RNA modification in heart failure remodeling","volume":"10","author":"Yang","year":"2023","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.tranon.2026.102986_bib0015","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2478\/jtim-2023-0103","article-title":"N(6)-methylation in the development, diagnosis, and treatment of gastric cancer","volume":"12","author":"Wang","year":"2024","journal-title":"J. Transl. Intern. Med."},{"key":"10.1016\/j.tranon.2026.102986_bib0016","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1038\/s41580-025-00852-1","article-title":"Functions and therapeutic applications of pseudouridylation","volume":"26","author":"Luo","year":"2025","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.tranon.2026.102986_bib0017","article-title":"A five-pseudouridylation-associated-LncRNA classifier for primary prostate cancer prognosis prediction","volume":"13","author":"Zheng","year":"2022","journal-title":"Front. Genet."},{"key":"10.1016\/j.tranon.2026.102986_bib0018","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.7150\/ijbs.100905","article-title":"FOXA1-dependent PUS1 regulates EIF3b stability in a non-enzymatic pathway mediating prostate cancer bone metastasis","volume":"20","author":"Wu","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.tranon.2026.102986_bib0019","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s12964-024-01977-0","article-title":"GG-NER's role in androgen receptor signaling inhibitor response for advanced prostate cancer","volume":"22","author":"Zhong","year":"2024","journal-title":"Cell Commun. Signal."},{"key":"10.1016\/j.tranon.2026.102986_bib0020","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","article-title":"EdgeR: a bioconductor package for differential expression analysis of digital gene expression data","volume":"26","author":"Robinson","year":"2010","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.102986_bib0021","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol."},{"key":"10.1016\/j.tranon.2026.102986_bib0022","doi-asserted-by":"crossref","first-page":"D1590","DOI":"10.1093\/nar\/gkaf911","article-title":"Rare Cancer Explorer 1.0 (RaCE 1.0): a dedicated database and analytical platform focused on rare cancers","volume":"54","author":"Chen","year":"2026","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0023","doi-asserted-by":"crossref","DOI":"10.1093\/nar\/gkv007","article-title":"Limma powers differential expression analyses for RNA-sequencing and microarray studies","volume":"43","author":"Ritchie","year":"2015","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0024","first-page":"131","article-title":"GseaVis: an R package for enhanced visualization of gene set enrichment analysis in biomedicine","volume":"1","author":"Zhang","year":"2025","journal-title":"Med Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0025","first-page":"136","article-title":"Systematic investigation of tumor microenvironment and antitumor immunity with IOBR","volume":"1","author":"Fang","year":"2025","journal-title":"Med Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0026","article-title":"ClusterProfiler 4.0: a universal enrichment tool for interpreting omics data","volume":"2","author":"Wu","year":"2021","journal-title":"Innov"},{"key":"10.1016\/j.tranon.2026.102986_bib0027","article-title":"Extended application of genomic selection to screen multiomics data for prognostic signatures of prostate cancer","volume":"22","author":"Li","year":"2021","journal-title":"Br. Bioinform."},{"key":"10.1016\/j.tranon.2026.102986_bib0028","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1158\/0008-5472.CAN-21-3074","article-title":"Comprehensive evaluation of machine learning models and gene expression signatures for prostate cancer prognosis using large population cohorts","volume":"82","author":"Li","year":"2022","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0029","doi-asserted-by":"crossref","first-page":"4488","DOI":"10.1093\/bioinformatics\/btz229","article-title":"RTNsurvival: an R\/bioconductor package for regulatory network survival analysis","volume":"35","author":"Groeneveld","year":"2019","journal-title":"Bioinformatics"},{"key":"10.1016\/j.tranon.2026.102986_bib0030","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/1755-8794-3-21","article-title":"SEURAT: visual analytics for the integrated analysis of microarray data","volume":"3","author":"Gribov","year":"2010","journal-title":"BMC Med. Genom."},{"key":"10.1016\/j.tranon.2026.102986_bib0031","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1158\/0008-5472.CAN-23-2650","article-title":"The web-based portal SpatialTME integrates histological images with single-cell and spatial transcriptomics to explore the tumor microenvironment","volume":"84","author":"Shi","year":"2024","journal-title":"Cancer Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0032","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41467-023-36560-7","article-title":"Reconstruction of the tumor spatial microenvironment along the malignant-boundary-nonmalignant axis","volume":"14","author":"Xun","year":"2023","journal-title":"Nat. Commun."},{"key":"10.1016\/j.tranon.2026.102986_bib0033","doi-asserted-by":"crossref","DOI":"10.1002\/imt2.43","article-title":"Complex heatmap visualization","volume":"1","author":"Gu","year":"2022","journal-title":"Imeta"},{"key":"10.1016\/j.tranon.2026.102986_bib0034","first-page":"73","article-title":"Transcriptional and epigenetic reprogramming, lineage plasticity and therapy resistance in prostate cancer","volume":"6","author":"Shuai","year":"2026","journal-title":"J. Natl. Cancer Cent."},{"key":"10.1016\/j.tranon.2026.102986_bib0035","doi-asserted-by":"crossref","DOI":"10.71321\/q01vae55","article-title":"Multidimensional roles of EZH2 and its therapeutic potential in cancer TherapyReview article","volume":"1","author":"Yin","year":"2025","journal-title":"Life Conflux"},{"key":"10.1016\/j.tranon.2026.102986_bib0036","first-page":"991","article-title":"miR\u2011505 suppresses prostate cancer progression by targeting NRCAM","volume":"42","author":"Ling","year":"2019","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.tranon.2026.102986_bib0037","first-page":"53","article-title":"Direct RNA sequencing enables improved transcriptome assessment and tracking of RNA modifications for medical applications","author":"Hewel","year":"2025","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0038","doi-asserted-by":"crossref","DOI":"10.71321\/lcflx.00001","article-title":"Integrating machine learning and multi-omics to identify key SUMOylation molecular signature in sarcoma","volume":"1","author":"Cheng","year":"2024","journal-title":"Life Conflux"},{"key":"10.1016\/j.tranon.2026.102986_bib0039","first-page":"54","article-title":"Multimodal profiling reveals cell type-specific pseudouridine modification and density-dependent translational regulation","author":"McCormick","year":"2026","journal-title":"Nucleic. Acids. Res."},{"key":"10.1016\/j.tranon.2026.102986_bib0040","doi-asserted-by":"crossref","DOI":"10.1016\/j.molcel.2021.12.023","article-title":"Pseudouridine synthases modify human pre-mRNA co-transcriptionally and affect pre-mRNA processing","volume":"82","author":"Martinez","year":"2022","journal-title":"Mol. Cell."},{"key":"10.1016\/j.tranon.2026.102986_bib0041","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1038\/s41418-023-01175-4","article-title":"SUMO specific peptidase 3 halts pancreatic ductal adenocarcinoma metastasis via deSUMOylating DKC1","volume":"30","author":"Wu","year":"2023","journal-title":"Cell Death. Differ."},{"key":"10.1016\/j.tranon.2026.102986_bib0042","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116233","article-title":"Pseudouridine synthase 1-targeted therapy activates antiviral immunity to boost cancer immunotherapy","volume":"44","author":"Wang","year":"2025","journal-title":"Cell Rep."},{"key":"10.1016\/j.tranon.2026.102986_bib0043","doi-asserted-by":"crossref","DOI":"10.1002\/advs.202004344","article-title":"Dual inhibition of DKC1 and MEK1\/2 synergistically restrains the growth of colorectal cancer cells","volume":"8","author":"Kan","year":"2021","journal-title":"Adv. Sci."},{"key":"10.1016\/j.tranon.2026.102986_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/ctm2.1811","article-title":"PUS7-dependent pseudouridylation of ALKBH3 mRNA inhibits gastric cancer progression","volume":"14","author":"Chang","year":"2024","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.tranon.2026.102986_bib0045","doi-asserted-by":"crossref","first-page":"3568","DOI":"10.1038\/s41388-025-03511-z","article-title":"PKA-driven SPP1 activation as a novel mechanism connecting the bone microenvironment to prostate cancer progression","volume":"44","author":"Sanchis","year":"2025","journal-title":"Oncogene"},{"key":"10.1016\/j.tranon.2026.102986_bib0046","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-11897-9","article-title":"Elevated co-expression of TIMM17A and NMT1 is associated with poor survival in non-small cell lung cancer","volume":"15","author":"Chan","year":"2025","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.102986_bib0047","doi-asserted-by":"crossref","first-page":"8840","DOI":"10.1038\/s41598-024-59526-1","article-title":"TIMM17A overexpression in lung adenocarcinoma and its association with prognosis","volume":"14","author":"Miao","year":"2024","journal-title":"Sci. Rep."},{"key":"10.1016\/j.tranon.2026.102986_bib0048","first-page":"1237","article-title":"The impact of TIMM17A on aggressiveness of Human breast cancer cells","volume":"36","author":"Yang","year":"2016","journal-title":"Anticancer Res."}],"container-title":["Translational Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936523326003220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:33:47Z","timestamp":1790739227000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936523326003220"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":48,"alternative-id":["S1936523326003220"],"URL":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102986","relation":{},"ISSN":["1936-5233"],"issn-type":[{"value":"1936-5233","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The pseudouridine epitranscriptomic landscape of advanced prostate cancer therapeutic resistance identifies TIMM17A as a key player","name":"articletitle","label":"Article Title"},{"value":"Translational Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.tranon.2026.102986","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"102986"}}